![]() |
市场调查报告书
商品编码
1746995
日本介入性心臟病学设备市场报告(按产品(支架、介入导管、PTCA导丝、球囊充气装置、PTCA球囊)、最终用户(医院、门诊手术中心等)和地区)2025-2033 年Japan Interventional Cardiology Devices Market Report by Product (Stents, Interventional Catheters, PTCA Guidewires, Balloon Inflation Device, PTCA Balloons), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2025-2033 |
2024年,日本介入性心臟病学设备市场规模达11亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到24亿美元,2025-2033年期间的复合年增长率(CAGR)为8.3%。心臟病盛行率的上升、医疗技术的进步、扶持政策的出台,以及人们对微创(MI)手术而非传统手术的日益青睐,是推动市场发展的一些关键因素。
介入性心臟病学器械是指用于导管治疗结构性心臟病的各种专用工具和设备,包括支架、导管、导丝、球囊和血管闭合装置等。介入性心臟病学器材具有多种特点,包括微创 (MI)、精准性、灵活性和先进的技术整合。它们广泛应用于各种领域,包括血管成形术、支架置入术、瓣膜成形术、先天性心臟缺陷矫正术、经皮瓣膜修復术和冠状动脉血栓切除术。介入性心臟病学器械有助于改善患者预后、缩短復原时间、降低感染风险、最大程度减少住院时间、减轻手术不适并提高诊断准确性。此外,它们还以其长期成本效益高、手术风险低、成功率高以及能够满足不适合开胸心臟外科手术的高风险患者的需求而闻名。
老年族群中心臟病盛行率的上升,导致对包括介入手术在内的先进心臟护理的需求增加,推动了市场的成长。此外,高血压、肥胖症和糖尿病等生活型态相关疾病的日益流行,也增加了心血管疾病的风险,进而推动了市场的成长。此外,医疗技术的最新进步,推动了更先进、更有效的介入性心臟病学设备的开发,也对市场成长产生了正面的影响。此外,政府推出的支持性政策和对医疗基础设施的投资,也促进了市场的成长。此外,由于心肌梗塞(MI)手术恢復时间更短、风险更低,人们越来越倾向于选择传统手术,这也催化了市场的成长。此外,医疗支出的不断增长,加上先进医疗程序的保险覆盖范围不断扩大,也为市场成长提供了显着的推动力。此外,越来越多的专科心臟科医师和具备介入性心臟病学能力的医疗机构,也对市场成长产生了正面的影响。同时,全球和本地领先医疗器材公司在技术转移和产品开发方面日益加强的合作与伙伴关係,也刺激了市场成长。此外,日本民众对心血管疾病及其治疗的认识不断提高,也推动了市场成长。此外,旨在提高介入性心臟病学器材有效性和安全性的持续研究和临床试验,也正在增强市场成长。此外,医疗保健基础设施的显着改善,包括可支持介入性心臟病学器材应用的先进医疗设施的出现,也正在推动市场成长。此外,支持介入性心臟病学器材有效性和安全性的强有力临床证据的广泛存在,也有利于市场成长。
市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。
Japan interventional cardiology devices market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.4 Billion by 2033, exhibiting a growth rate (CAGR) of 8.3% during 2025-2033. The rising prevalence of cardiac ailments, recent advancements in medical technology, introduction of supportive policies, and the growing preference for minimally invasive (MI) procedures over traditional surgeries represent some of the key factors driving the market.
Interventional cardiology devices refer to a broad range of specialized tools and equipment utilized in the catheter-based treatment of structural heart diseases. They include stents, catheters, guidewires, balloons, and vascular closure devices, among others. Interventional cardiology devices possess various features, including minimally invasive (MI) nature, precision, flexibility, and advanced technological integration. They are employed in a variety of applications, including angioplasty, stent placement, valvuloplasty, congenital heart defect correction, percutaneous valve repair, and coronary thrombectomy. Interventional cardiology devices aid in improving patient outcomes, reducing recovery times, lowering the risk of infection, minimizing hospital stays, decreasing procedural discomfort, and enhancing diagnostic accuracy. In addition, they are known for their cost-effectiveness in the long term, lower surgical risks, high success rates, and ability to cater to high-risk patients who are not candidates for open-heart surgery.
The rising prevalence of cardiac ailments in the geriatric population, contributing to the heightened demand for advanced cardiac care, including interventional procedures, is propelling the market growth. Additionally, the increasing prevalence of lifestyle-related diseases, such as hypertension, obesity, and diabetes, which escalates the risk of cardiovascular diseases, is driving the market growth. Besides this, recent advancements in medical technology, leading to the development of more sophisticated and effective interventional cardiology devices, are positively influencing the market growth. Furthermore, the introduction of supportive policies and investments by the government in healthcare infrastructure is bolstering the market growth. In addition, the growing preference for MI procedures over traditional surgeries, owing to their reduced recovery times and lower risks, is catalyzing the market growth. Apart from this, the rising healthcare expenditure, coupled with enhanced insurance coverage for advanced medical procedures, is providing a considerable boost to the market growth. Moreover, the increasing number of specialized cardiologists and healthcare facilities that are equipped to perform interventional cardiology are positively affecting the market growth. Along with this, the growing collaboration and partnerships among leading global and local medical device companies for technology transfer and product development are stimulating the market growth. In addition, the rising awareness about cardiovascular diseases and their treatments among the Japanese population is driving the market growth. Furthermore, the ongoing research and clinical trials aiming to improve the efficacy and safety of interventional cardiology devices are strengthening the market growth. Besides this, the significant improvements in healthcare infrastructure, including the availability of advanced medical facilities that can support the adoption of interventional cardiology devices, are fueling the market growth. Additionally, the widespread availability of strong clinical evidence supporting the effectiveness and safety of interventional cardiology devices is favoring the market growth.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.